Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Braskem S.A.NYSE: BAK

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue declines year over year

Q1 FY2026 revenue of R$15.49B fell 20.4% year over year, behind the -15.5% change in trailing-twelve-month revenue. Sequentially, it fell 3.8% from the prior quarter. Over 3 fiscal years it compounded at -10.4% a year.

Context

  • Revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of R$74.38B (+7.3%) for the fiscal year ending Dec 2026, a step up from the -10.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
R$15.49B-3.8% QoQ
Last fiscal yearDec 2025
R$69.33B-10.4% YoY
LTMMar 2026
R$66.75B-15.5% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.4%+24.9%+45.3 pp
1 year-10.4%+7.3%+17.7 pp
3-year CAGR-10.4%+2.7%+13.1 pp
5-year CAGR-0.4%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

BRL · from the income statement

Latest · FY2025
69.33B BRL
Year-over-year change
-10.4%
4-year CAGR
-10.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -15.5% is the lowest of 9, against a peer median of +16.2%.
  • Over three fiscal years its annual growth of -10.4% compares with a peer median of -5.6%.
BAK Competitors
Revenue for BAK and competitors
Company Period LTM YoY 3-year CAGR
BAKBraskem S.A.LTM Mar 2026R$66.75B BRL-15.5%-10.4%
SCLStepan CompanyLTM Mar 2026$2.34B USD+5.5%-5.6%
RYAMRayonier Advanced Materials Inc.LTM Mar 2026$1.43B USD-10.6%-5.1%
WLKPWestlake Chemical Partners LPLTM Mar 2026$1.23B USD+13.4%-9.9%
ECVTEcovyst Inc.LTM Mar 2026$819.42M USD+19.3%-4.1%
REXREX American Resources CorporationLTM Apr 2026$656.2M USD+2.6%-8.7%
UANCVR Partners, LPLTM Mar 2026$643.22M USD+19.0%-10.2%
MUXMcEwen Mining Inc.LTM Mar 2026$235.91M USD+39.6%+21.4%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$26.93M USD+511.2%—
CNLCollective Mining Ltd.LTM Mar 2026$0 USD——
NAKNorthern Dynasty Minerals Ltd.LTM Mar 2026CA$0 CAD——
Peer median (excluding BAK) —+16.2%-5.6%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue105.63B96.52B70.57B77.41B69.33B
Cost of Revenue73.57B85.16B67.55B71.41B67.8B
Gross Profit32.06B11.36B3.02B6B1.53B
Gross Margin30.3%11.8%4.3%7.7%2.2%
Research & Development297M374M383M463M450.96M
Selling, General & Admin4.58B4.87B4.39B4.63B4.68B
Operating Expenses4.88B5.25B4.77B4.99B5.48B
Depreciation & Amortization4.18B4.73B5.21B3.75B4.58B
EBITDA25.33B8.11B3.26B2.7B631.35M
EBITDA Margin24.0%8.4%4.6%3.5%0.9%
Operating Income27.18B6.11B(1.75B)1.01B(3.95B)
Operating Margin25.7%6.3%-2.5%1.3%-5.7%
Interest Income440M1.05B873M1.26B711.74M
Interest Expense3.19B3.33B4.78B5.44B5.82B
Other Income / Expenses(9.22B)(6.07B)(4.44B)(18.75B)1.16B
Income Before Tax17.96B47M(6.19B)(17.73B)(2.79B)
Pre-Tax Margin17.0%0.0%-8.8%-22.9%-4.0%
Income Tax Expense4B868M(1.3B)(5.68B)7.96B
Net Income13.99B(336M)(4.58B)(11.32B)(9.69B)
Net Margin13.2%-0.3%-6.5%-14.6%-14.0%
EPS (Basic)35.12(2.06)(11.50)(28.40)(24.32)
EPS (Diluted)35.08(2.06)(11.50)(28.40)(24.32)
Weighted Avg Shares398.11M398.24M398.35M398.6M398.6M
Weighted Avg Shares (Diluted)398.61M398.6M398.35M398.6M398.6M

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.